A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
The US Food and Drug Administration announced this month that it's effectively banning Red No. 3, the controversial ...
Suzetrigine is an orally available pain signal inhibitor that selectively targets the NaV1.8 voltage-gated sodium channel, a genetically validated pain target found on peripheral neurons. NaV1.8 is ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...
“It's not only the first full-spectrum cannabinoid ... The Unique Situation of a Botanical Drug Candidate Approval Process, and Autism As a botanical drug candidate, the road to approval is ...
"Autism detox" treatments, which include minerals like zeolite, are rising in popularity for promising to treat or reverse the diagnosis. Experts warn there is no science behind these claims.